223 results
Page 4 of 12
8-K
EX-10.4
61k25z7r9nasl
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.1
bvz iw426jboa40
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.3
ozkp85xa8j 7q5llid
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.2
sv9j89ht3n8s4r63mc
10 Jul 08
Departure of Directors or Principal Officers
12:00am
S-8
EX-10.1
quaaubt
13 Jun 08
Registration of securities for employees
12:00am
S-8
EX-10.1
7j1t7j5
12 Jun 08
Registration of securities for employees
12:00am
8-K
EX-10.1
wsa4ohx4yo pdnq
24 Mar 08
Acura Pharmaceuticals, Inc. Names
12:00am
8-K
EX-10.1
ahd4an7zl4kcbbr9h
28 Jan 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
bxpnfxqzujw9q32 il
2 Nov 07
Entry into a Material Definitive Agreement
12:00am
S-3
EX-10.4
2owab6t
1 Oct 07
Shelf registration
12:00am
S-3
EX-10.6
2fr2c gnuf75xx
1 Oct 07
Shelf registration
12:00am
S-3
EX-10.5
5348zoqnl1mvjv4z9re
1 Oct 07
Shelf registration
12:00am
S-3
EX-10.3
28ywimb8gk5i 2iy
1 Oct 07
Shelf registration
12:00am
8-K
EX-10.2
y0x53rj1nvu40 r0
24 Sep 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jpsvtqqsdrckn
24 Sep 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
2xn16q ff12zxf8e
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am